-
Venezuela, Colombia pledge military cooperation on first post-Maduro visit
-
US hopes for progress, but Iran says not direct talks
-
Maine governor nixes data center moratorium in state
-
Betis's Bellerin further dents Real Madrid title hopes
-
Lens rally but title bid fades after draw at Brest
-
OpenAI CEO apologizes to Canada town for not reporting mass shooter
-
UK PM vows legislation to ban Iran Guards: report
-
Leipzig tighten top-four grip as Union's Eta suffers second loss
-
Furyk named USA captain for 2027 Ryder Cup
-
EU, US sign critical minerals plan to counter China reliance
-
The 'housewives' did well -- Ukraine takes drone know-how abroad
-
Court removes US businessman from managing his Brazilian football team
-
'Natural' birth control risks unwanted pregnancy, experts warn
-
No.2 Korda boosts LPGA Chevron lead to seven
-
EU trade chief seeks 'positive traction' on US steel tariffs
-
Anthropic says Google to pump $40 bn into AI startup
-
Kohli makes Gujarat pay as Bengaluru cruise to IPL win
-
One injured in bomb attack on Colombia military base
-
Envoys from Iran, US expected in Pakistan for new talks
-
ILO names US official as number two amid grumbling over unpaid dues
-
Son of director Rob Reiner pays tribute to slain parents
-
AI united Altman and Musk, then drove them apart
-
Sinner overcomes Bonzi in record hunt at Madrid Open
-
Havana property market stirs as investors bet on political change
-
Children's lives at risk from US funding cuts to vaccine alliance: CEO
-
Brazil's Lula has surgery to remove skin lesion from scalp
-
Defending champion Alcaraz to miss French Open with wrist injury
-
Battle lines drawn over EU's next big budget
-
Renewed hopes of Iran peace talks keep oil under $100 per barrel
-
Lebanon truce extended as Pakistan bids to revive US-Iran talks
-
Assisted dying bill scuppered as UK advocates vow to fight on
-
Alex Marquez quickest in Spanish MotoGP practice
-
Former New Zealand cricketer Bracewell given two-year ban for cocaine use
-
Justice Dept ends criminal probe into US Fed chair Powell
-
Merz says no 'immediate' Ukraine EU membership, floats Kyiv joining meetings
-
G7 says nature talks a success as climate sidelined for US
-
'Hands off': Teddy bear tale teaches French preschoolers consent
-
Russia, Ukraine swap 193 POWs
-
'We have to be stronger': De Zerbi demands Spurs improve as relegation fears mount
-
Man City will not risk Rodri in FA Cup semi-final: Guardiola
-
Macron leaves future open as political curtain nears
-
Germany launches spying probe into Signal attacks targeting MPs
-
Arsenal haven't given up on title despite blowing lead: Arteta
-
Injured Spain star Yamal will come back stronger at World Cup: Flick
-
Oil prices fall on hopes of fresh Iran peace talks
-
Chelsea can still save season despite slump: McFarlane
-
Echoing Diana, Prince Harry visits Ukraine's deminers
-
Chelsea's Estevao out for season, World Cup in doubt
-
PSG's Luis Enrique 'couldn't care less' about World Cup
-
Ryanair says to cut Berlin flights, blaming taxes
Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting
LAS VEGAS, NV / ACCESS Newswire / May 20, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are in talks with an international healthcare innovation company to license or potentially acquire its patented early disease detection technology. If successful, it's a global license or acquisition that has the potential to revolutionize preventive health reporting and to generate correlations for future detection of new diseases without the need for all the patient's data.
Avant and Ainnova continue to grow the footprint and capabilities of their technology portfolio with the goal of being a leader in early disease detection using the Company's signature AI-driven Vision AI technology platform.
Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said of the Company's aim to continue to add to its portfolio, "Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily. We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem.
"To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions."
Avant and Ainnova see the retina as a new vital sign, but also understand that leveraging the results of laboratory tests and basic patient data can all work in concert to provide a comprehensive health report.
Vargas added, "We have already integrated an exclusive license for four algorithms into our Vision AI platform, and we are now in talks to license and potentially acquire an innovative technology that would be a game changer in our industry."
Avant will inform its shareholders of any updates at an appropriate time.
About Ainnova Tech, Inc.
Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.
About Avant Technologies Inc.
Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.
More information about Avant can be found at https://avanttechnologies.com
You can also follow us on social media at:
https://twitter.com/AvantTechAI
https://linkedin.com/company/avant-technologies-ai
https://www.facebook.com/AvantTechAI
https://www.youtube.com/@AvantTechAI
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.
Contact:
Avant Technologies Inc.
[email protected]
SOURCE: Avant Technologies
View the original press release on ACCESS Newswire
C.Garcia--AMWN